(Q36286945)

13 August 2017

1 reference

title

Site-specific effect of chemotherapy in patients with breast cancer (English)

1 reference

13 August 2017

Kamby C

1

1 reference

PubMed ID

1622638

13 August 2017

Vestlev PM

series ordinal

2

1 reference

PubMed ID

1622638

13 August 2017

Mouridsen HT

series ordinal

3

1 reference

13 August 2017

1 January 1992

1 reference

13 August 2017

1 reference

13 August 2017

31

1 reference

13 August 2017

2

1 reference

13 August 2017

225-229

1 reference

Response of metastatic breast cancer to combination chemotherapy according to site

13 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

The clonal evolution of tumor cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

The pathogenesis of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

'Seed and soil' revisited: mechanisms of site-specific metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

The distribution of secondary growths in cancer of the breast. 1889

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

21 January 2018

DYNAMICS OF TUMOR GROWTH

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

Natural history and prognosis of recurrent breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

The influence of various factors on metastases in carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

The pattern of metastases in human breast cancer: methodological aspects and influence of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

Response and survival in advanced breast cancer after two non-cross-resistant combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy. A subset analysis of CALGB Study 8081.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

Combined cytotoxic and endocrine therapy in postmenopausal patients with advanced breast cancer. A randomized study of CMF vs CMF plus tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

Cancer of the breast: the past decade (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869209088907

10.3109/02841869209088907

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

1622638